SCHEMBL2364223

SCHEMBL2364223

COCc1cc(-c2ccnc(N(C)c3cccc(Cl)c3)n2)ccn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 4/20 0.39
▸ CSF1R P07333 2/20 0.39
▸ DYRK1A Q13627 3/20 0.39
▸ GRM4 Q14833 1/20 0.38
▸ CLK4 Q9HAZ1 2/20 0.37
▸ DYRK1B Q9Y463 2/20 0.37
▸ CLK1 P49759 1/20 0.37
▸ CLK2 P49760 1/20 0.37
▸ KMO O15229 1/20 0.37
▸ RXRA P19793 1/20 0.36
▸ RXRB P28702 1/20 0.36
▸ RXRG P48443 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ PLK1 P53350 1/20 0.36
▸ HTT P42858 1/20 0.35
▸ TAAR1 Q96RJ0 1/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ BCR P11274 1/20 0.34
▸ PRKCA P17252 1/20 0.34
▸ PRKCD Q05655 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2951568 0.69 KMO (0.44) KMOMAPTPLK1ABL1BCR
SCHEMBL14028480 0.69 GSK3B (0.45) GRM4KMOMAPTPLK1
SCHEMBL2089511 0.69 S1PR4 (0.46) RXRAMAPTS1PR4LMNATDP1
SCHEMBL27116531 0.68 DYRK1A (0.54) CSF1RDYRK1ACLK4DYRK1BCLK1
SCHEMBL27116411 0.67 KMO (0.44) DYRK1ACLK4DYRK1BCLK1CLK2
SCHEMBL27154223 0.67 DYRK1A (0.48) DYRK1ACLK4DYRK1BCLK1CLK2
SCHEMBL4947246 0.66 EGFR (0.47) EGFRCSF1RDYRK1AGRM4CLK4
SCHEMBL10973666 0.65 GSK3B (0.55) EGFRDYRK1ACLK4DYRK1BCLK1
SCHEMBL27138987 0.64 KMO (0.47) EGFRCSF1RDYRK1ACLK4DYRK1B
SCHEMBL10973799 0.64 GSK3B (0.51) DYRK1ACLK4DYRK1BCLK1CLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110294810-A1 SUBSTITUTED (PYRIDYL)-AZINYLAMINE DERIVATIVES AS PLANT PROTECTION AGENTS BAYER CROPSCIENCE AG (DE) 2011-12-01 — — US disclosed
CN-102216286-A Substituted (pyridyl)-azinylamine derivatives as plant protection agents BAYER CROPSCIENCE SA 2011-10-12 — — CN disclosed
EP-2356102-A1 SUBSTITUTED (PYRIDYL)-AZINYLAMINE DERIVATIVES AS PLANT PROTECTION AGENTS Bayer CropScience AG (DE) 2011-08-17 — — EP disclosed
WO-2010055114-A1 SUBSTITUTED (PYRIDYL)-AZINYLAMINE DERIVATIVES AS PLANT PROTECTION AGENTS BAYER CROPSCIENCE SA (FR) 2010-05-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294810-A1 SUBSTITUTED (PYRIDYL)-AZINYLAMINE DERIVATIVES AS PLANT PROTECTION AGENTS PRXL2A, AZI2, PIR EGFR 4246/4885CSF1R 4602/4885DYRK1A 1285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback